 WOODSTOCK, Ga.--BUSINESS WIRE--Sonoma Pharmaceuticals, Inc. Nasdaq: SNOA, a global healthcare leader developing and producing stabilized hypochlorous acid HOCl products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its second fiscal quarter and six months ended September 30, 2020. It further announced that it had to restate its first quarter financial statements for the quarter en 